GlassScriptPhysician profile
Jose R Baez
NPI 1336103233
$31,728.89
in general payments reported to CMS, 2019-2025
64 companies · $5,684 in 2025
The $5,684 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,497 · 2020: $3,407 · 2021: $4,904 · 2022: $4,330 · 2023: $4,212 · 2024: $3,694 · 2025: $5,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $4.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,586.54 |
| Education | $4.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,655.47 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $4,979.67 | 2019-2025 | Linzess, Vraylar, Viberzi |
| Novo Nordisk INC | $1,597.95 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $1,442.04 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $1,355.46 | 2019-2025 | Jardiance, Kisunla, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,336.60 | 2019-2025 | Jardiance |
| Amgen INC. | $1,325.81 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $1,204.77 | 2019-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $1,131.67 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Pfizer INC. | $1,129.40 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,097.07 | 2019-2024 | Trulance, Uceris, Xifaxan |
| Janssen Pharmaceuticals, INC | $755.50 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $713.38 | 2019-2025 | |
| Allergan, INC. | $592.73 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $553.55 | 2021-2025 |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Baez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.